روزوڤاساتين تيڤع ١٠ ملغ إسرائيل - العربية - Ministry of Health

روزوڤاساتين تيڤع ١٠ ملغ

teva pharmaceutical indust.ltd - rosuvastatin as calcium 10 mg - tablets - rosuvastatin - primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate. homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate.

پروكتوصورين-ن إسرائيل - العربية - Ministry of Health

پروكتوصورين-ن

teva pharmaceutical indust.ltd - allantoin 2 %; aluminium acetotartrate 0.4 % - ointment - benzocaine - for the relief of pain and inflammation caused by hemorrhoids.

موپيروسين تيڤع إسرائيل - العربية - Ministry of Health

موپيروسين تيڤع

teva pharmaceutical indust.ltd - mupirocin 2 % - ointment - mupirocin - acute primary bacterial skin infections susceptible to the drug e.g. impetigo and folliculitis.

تيڤاعديرم إسرائيل - العربية - Ministry of Health

تيڤاعديرم

teva pharmaceutical indust.ltd - diflucortolone valerate 0.1 %; isoconazole nitrate 1 % - cream - diflucortolone - for the local treatment of inflammatory skin conditions accompanied by secondary fungal infections.

تيرازوسين تيڤع ٥ ملغ إسرائيل - العربية - Ministry of Health

تيرازوسين تيڤع ٥ ملغ

teva pharmaceutical indust.ltd - terazosin as hydrochloride dihydrate 5 mg - tablets - terazosin - for symptomatic treatment of urinary obstructon caused by benign prostatic hyperplasia (bph). for mild to moderate hypertension.

أناستروزول تيڤع إسرائيل - العربية - Ministry of Health

أناستروزول تيڤع

teva pharmaceutical indust.ltd - anastrozole 1 mg - tablets - anastrozole - treatment of advanced breast cancer in post menopausal women. efficay has not been demonstrated in estrogen receptor negative patients unless they had a previous positive clinical response to tamoxifen. adjuvant treatment of postmenopausal women with hormone receptor positive early invasive breast cancer. adjuvant treatment of early breast cancer in hormone receptor positive postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen.

ليتروزول تيڤع إسرائيل - العربية - Ministry of Health

ليتروزول تيڤع

teva pharmaceutical indust.ltd - letrozole 2.5 mg - tablets - letrozole - letrozole teva tablets is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whom hormone receptor status cannot be determined, locally advanced or metastatic breast cancer: letrozole teva is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

ايتودولاك ER تيڤع ٤٠٠ ملغ إسرائيل - العربية - Ministry of Health

ايتودولاك er تيڤع ٤٠٠ ملغ

teva pharmaceutical indust.ltd - etodolac 400 mg - tablets - etodolac - for the management of signs and symptoms of osteoarthritis and rehumatoid arthritis.

أليندرونات تيڤع ٧٠ ملغ إسرائيل - العربية - Ministry of Health

أليندرونات تيڤع ٧٠ ملغ

teva pharmaceutical indust.ltd - alendronic acid as sodium 70 mg - tablets - alendronic acid - for the treatment of osteoporosis in postmenopausal women to prevent fractures, including those of the hip and spine (vertebral compression fractures).treatment to increase bone mass in men with osteoporosis.

كود أكامول ١٥/٣٢٥ إسرائيل - العربية - Ministry of Health

كود أكامول ١٥/٣٢٥

teva pharmaceutical indust.ltd - codeine phosphate 15.0 mg; paracetamol 325 mg - tablets - paracetamol, combinations excl. psycholeptics - relief of mild to moderate pain. relief of fever and cough associated with fever.